Nanoscope Therapeutics announces positive results from phase 2b trial in Retinitis Pigmentosa
March 31, 2023Medical Communications
US-based Nanoscope Therapeutics has announced topline results from its phase 2b RESTORE clinical trial. Currently, patients with vision loss due …
Expansion of Scientific Affairs Group
March 30, 2023Business Services
Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an …
Roz Bekker appointed Managing Director of Janssen UK & Ireland
March 30, 2023Business Services
High Wycombe, UK, 30 March 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson are pleased to introduce Roz …
Granular Therapeutics to accelerate development of next-generation pipeline for treating mast cell driven diseases
March 30, 2023Business Services
London, UK, March 30, 2023 – Granular Therapeutics, (Granular) a private biotech company specialising in precision biologic therapies for treating …
Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics
March 30, 2023Business Services
Netanya, Israel, March 30, 2023 – Trobix Bio, a company utilizing CRISPR, phage, and synthetic biology technologies to develop advanced …
PHARMANOVIA EXPANDS EXCLUSIVE LICENSING COLLABORATION WITH AQUESTIVE THERAPEUTICS FOR DIAZEPAM BUCCAL FILM
March 30, 2023Business Services
Basildon, UK – For immediate release, 27 March 2023 Pharmanovia, a global pharmaceutical company that revitalises, extends and expands …
Unite Health: Thousands Honor Pandemic ‘Influencers’ Through COVID-19 Social Media Awards
March 30, 2023Business Services
London, UK | In a global display of appreciation, thousands of people are recognizing social media influencers who used …
UK and Polish regulatory authorities approve Akari Therapeutics’ higher-yielding manufacturing process
March 30, 2023Manufacturing and Production
Akari Therapeutics has announced that the UK’s MHRA and the Polish Office for Registration of Medicinal Products, Medical Devices and …
Hovione and Laxxon Medical sign partnership over 3D printed pharmaceutical applications
March 30, 2023Medical Communications
Hovione, a CDMO, and Laxxon Medical, a pharma-technology company, have signed a strategic partnership deal to bring 3D printing technologies …
Janssen reports new Rybrevant data for patients with advanced non-small cell lung cancer
March 30, 2023Research and Development
Janssen, part of Johnson & Johnson, has announce new long-term data from its CHRYSALIS study, which assessed Rybrevant (amivantamab) in …
Alzheimer’s drug Leqembi expected to generate $12.9bn in sales by 2028
March 30, 2023Sales and Marketing
After receiving FDA approval in January 2023, Biogen/Eisai’s new Alzheimer’s disease Leqembi is expected to become a blockbuster, with a …
Netris Pharma doses first patient in pancreatic cancer study
March 29, 2023Research and Development
Netris Pharma has announced that it has dosed its first patient in the Lap-NET1 study for the safety and efficacy …
AbbVie’s upadacitinib meets primary endpoint in trial for systemic lupus erythematosus
March 29, 2023Research and Development
AbbVie has shared that upadacitinib (Rinvoq) has been shown to be effective in treating patients with moderately-to-severely-active systemic lupus erythematosus …
Genialis raises $13m in Series A funding for the development of AI/ML patient classifiers
March 29, 2023Medical Communications
Genialis, a computational precision medicine company, has announced that it’s raised more than $13m in Series A funding, co-led by …
University of Dundee aids AI research for hypertension
March 29, 2023Medical Communications
The University of Dundee has announced its involvement in a Europe-wide project which will study whether AI can improve the …
Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B
March 28, 2023Business Services
OXFORD, United Kingdom, March 28, 2023 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company focused on the …
Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry
March 28, 2023Business Services
Milan, Italy, March 28, 2023, 12:30 pm CET – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company …
TEZSPIRE▼(TEZEPELUMAB) TO BE RECOMMENDED BY NICE AS AN ADD-ON TREATMENT FOR SEVERE UNCONTROLLED ASTHMA
March 28, 2023Business Services
London, UK, Tuesday 28 March 2023 – AstraZeneca today announced that the National Institute for Health and Care Excellence (NICE) …
Tavneos® (avacopan) included in updated EULAR recommendations for the management of AAV
March 28, 2023Business Services
ST. GALLEN, Switzerland, March 28, 2023 /PRNewswire/ — Vifor Fresenius Medical Care Renal Pharma (VFMCRP) is pleased to announce that …
iOnctura awarded UK’s MHRA Innovation Passport for entry into innovative licensing and access pathway (ILAP)
March 28, 2023Business Services
Geneva, Switzerland and Amsterdam, The Netherlands, 28 March – iOnctura, a clinical stage biotechnology company developing breakthrough therapies for patients …
